Bright Minds Biosciences | 20-F:2024财年年报
Bright Minds Biosciences | 6-K:Bright Minds Biosciences将在 2024年美国癫痫学会年会上公布数据
Bright Minds Biosciences | D:发行公告
Bright Minds Biosciences | SC 13G:超过5%持股股东披露文件-RA Capital Management, L.P.(6.6%),Peter Kolchinsky(6.6%)等
Bright Minds Biosciences | 4:持股变动声明-股东 Cormorant Asset Management, LP
Bright Minds Biosciences | SC 13G/A:超过5%持股股东披露文件(修正)-Cormorant Asset Management, LP(17.26%),Bihua Chen(17.26%)
Bright Minds Biosciences | SC 13D/A:超过5%持股股东披露文件(修正)-Ian McDonald(23.7%)
Bright Minds Biosciences | SC 13D/A:超过5%持股股东披露文件(修正)-Ian McDonald(24.4%)
Bright Minds Biosciences | 6-K:Bright Minds Biosciences完成3500万美元非经纪私募配售
Bright Minds Biosciences | SC 13G:超过5%持股股东披露文件-Commodore Capital LP(9.0%),Commodore Capital Master LP(9.0%)
Bright Minds Biosciences | SC 13G:超过5%持股股东披露文件-Logos Global Management LP(2.2%),Logos Global Management GP LLC(2.2%)等
Bright Minds Biosciences | SC 13G:超过5%持股股东披露文件-Point72 Asset Management, L.P.(9.7%),Point72 Capital Advisors, Inc.(9.7%)等
Bright Minds Biosciences | SC 13G:超过5%持股股东披露文件-Cormorant Global Healthcare Master Fund, LP(18.79%),Cormorant Global Healthcare GP, LLC(18.79%)等
Bright Minds Biosciences | SC 13G/A:超过5%持股股东披露文件(修正)-PFM Health Sciences, LP(0.0%),PFM Health Sciences GP, LLC(0.0%)等
Bright Minds Biosciences | D:发行公告
Bright Minds Biosciences | 6-K:突破性研究结束后,Bright Minds Biosciences和Firefly Neuroscience将合作
Bright Minds Biosciences | 6-K:Bright Minds Biosciences宣布进行3500万美元非经纪私募
Bright Minds Biosciences | 4:持股变动声明-股东 Cormorant Asset Management, LP
Bright Minds Biosciences | 3:首次持股声明-股东 Cormorant Asset Management, LP
Bright Minds Biosciences | SC 13G:超过5%持股股东披露文件-Perceptive Advisors LLC(9.6%),Joseph Edelman(9.6%)等